AUL
CVS icon

AlphaGrep UK Ltd’s CVS Health CVS Stock Holding History

AlphaGrep UK Ltd’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$268K Buy
+3,738
New +$288K 0.08% 564

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AlphaGrep UK Ltd's CVS Position: Q1 2026 in Review

AlphaGrep UK Ltd opened a new position in CVS Health (CVS) in Q1 2026: 3,738 shares worth $268K. The stake represents 0.08% of the portfolio and ranks #564 among its holdings.

1,875 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • AlphaGrep UK Ltd held 3,738 shares of CVS Health worth $268K as of Q1 2026.
  • CVS Health was a new AlphaGrep UK Ltd position in Q1 2026.
  • CVS Health made up 0.08% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #564 holding.
  • 1,875 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.